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Previous investigations have indicated  that the first of the four recognized 
components  of  complement exists  in  serum  as  a  proesterase which  may be 
activated  by  antigen-antibody  aggregates  (1-3),  by plasmin  (1),  or,  in  the 
partially  purified  state,  by  adjustment  of  physico-chemical  conditions  (4). 
The active esterase hydrolyzed certain synthetic amino acid esters, among which 
N-acetyl-L-tyrosine ethyl ester was most susceptible (3-5). This substrate was hy- 
drolyzedmaximally between pH 7.5 and 8.2 and at 41°C. The esterase was inhibited 
by a heat-labile factor in human serum which did not appear to be related to any of 
the known components of complement, and by certain sulfbydryl-containing reducing 
agents. The esterase could not be identified  with other known hydrolytic enzymes of 
serum (5) 
The possible role of the first component of complement (CPl) as a  proenzyme was 
first suggested by studies of the mechanism of inactivation of human complement by 
plasmin and by antigen-antibody aggregates (1, 2).  Subsequently, two independent 
lines  of evidence appeared to substantiate this hypothesis. In the first approach (3), 
an esterasewith complement-inactivating activity could be eluted from antigen-anti- 
body aggregates which had been treated with CJl-containing serum reagents. In the 
second approach  (4),  with which  the present report is further concerned,  C~I was 
partially purified at pH 5.5 and at low temperatures and was brought into the soluble 
phase only at relatively high ionic strengths. Under these conditions,  the preparation 
retained its hemolytic activity in the presence of the second,  third, and fourth com- 
ponents of complement provided that it was maintained at pH 5.5, ionic strength 0.30 
until just before assay. However, when  the  C~I was first adjusted  to physiological 
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conditions, it lost its hemolytic activity and acquired instead the ability to inactivate 
the second and fourth components of complement and to hydrolyze certain synthetic 
amino acid esters. Preliminary experiments indicated that, under the conditions in- 
vestigated, a  correlation existed between the rate of disappearance of hemolytically 
active Cq and the rate of appearance of complement-inactivating  and esterase proper- 
ties. 
The  kinetics of  the  spontaneous activation of  the  partially purified  proesterase 
(C~I) have now been studied much more extensively. Activation has been found to 
follow the kinetics for second order autoeatalysis and to occur optimally at pH 7.3-7.7 
with an apparent energy of activation of 31,000 calories per mol. Activation was in- 
hibited by small concentrations of ethylenediaminetetraaeetate, by ionic strengths 
above 0.15, and by small concentrations of fresh serum. Experiments have also been 
performed  which  indicate that  the  proesterase  may be activated  by plasmin, thus 
substantiating an hypothesis presented earlier (1). The correlation obtained between 
disappearance of Ctl and appearance of esterase under the wide range of conditions 
investigated provides further direct evidence for the proesterase role of the first com- 
ponent of complement. 
Nomenclature and Materials 
First Component of Human Complement (C'1) was prepared  by the procedure described 
previously (4).  The partially purified C'I contained 17 to 25 per cent of the C'I activity 
present in the original serum with a  purification of 30-  to 50-fold,  representing about 0.6 
per cent of the original serum protein. It was heterogeneous in the ultracentrifuge, with at 
least three measurable components at pH 5.5 and ionic strength 0.30. There were no meas- 
urable amounts of the second and fourth components of complement, and only traces of the 
third component. In preparations concentrated 20-fold over the starting material, the con- 
centration of properdin (6) was about 8 units per ml. when the first component was prepared 
from serum, and 1 unit or less per ml. when it was prepared from serum from which most 
of the properdin had been removed by treatment with zymosan. Partially purified C'I also 
contained appreciable amounts of piasminogen. The plasmin which formed upon the addition 
of  streptokinase digested  fibrin, casein, para-toluenesulfonyl-L-ar~nine methyl  ester,  and 
L-lysine ethyl ester, known substrates of plasmin (7). The recently described clot-promoting 
fractions,  Christmas factor  (plasma  thromboplastin component)  (8)  and  Hageman factor 
(9),  were present in large amounts. In some preparations, traces of thrombin and perhaps 
prothrombin or procenvertin were present. Neither proaccelerin, cholinesterase,  nor acid or 
~alkaline phosphatase could be detected. The preparation of partially purified C'I was stored 
at pH 5.5 and ionic strength 0.30 at -25°C. 
Partially purified C'I lost its hemolytic activity and acquired complement-inactivating 
and esterase activities when adjusted to certain conditions of pH and ionic strength in the 
absence of inhibitors. This new product has been designated activated C'1, although it is 
recognized  that  the  complement-inactivating and  esterase  properties  are  not  necessarily 
derived from C'I itself (3).  In earlier studies, activated C'I was referred  to as "converted 
C'l" (3, 4). 
Human serum reagents deficient in the first,  second,  third, or fourth components of com- 
plement, designated R1, R2, R3, R4, respectively, were prepared by conventional procedures 
described in detail elsewhere  (10).  R1  and R2 were prepared by dialysis of serum against 
pH 5.5 acetate buffer of ionic strength 0.02.  R3 was prepared by treatment of serum with 
zymosan (11), and R4 by treatment with hydrazine (12). All reagents were diluted 1.5-fold 
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Sheep blood was collected weekly in an equal volume of Alsever's solution (13)  and main- 
rained at 1°C. The red cells were washed two times with 0.15 ~  NaCI, finally with barbital- 
Ca++-Mg  ++ buffer, and then suspended in buffer containing 4 units of rabbit hemolysin per 
mk to give a  final suspension of sensitized  sheep cells containing 2.5  X  105 cells/mmA This 
standardization was effected by reference to a  standard curve relating cell count and optic 
density at 550 rag. 
Barbital-Ca++-Mg ++ buffer  (10), for use in complement assays,  had a  pH  of 7.4 at ionic 
strength 0.15 and contained 1.5  X  IO  °4 ~s Ca++ and 5  X  100  ~ ~  Mg  ++. Sodium  phosphate 
/rafter was composed of 1.82  gin. of NaH~PO4.H20  and 16.75  gm. of Na~-IPO4-12 H20 per 
liter, and had a  pH  of  7.4 and ionic strength 0.15. Barbital-saline buffer  was prepared by 
dissolving 2.76 gin. of barbital, 2,06 gin. of sodium barbital, and 7.40 gin. of sodium chloride 
in one liter of water, and consisted of 0.025 M barbital, and 0.125 ~  sodium chloride at pH 
7.5  and  ionic strength 0.15.  Michadis' acetate-barbital-sallne  buffers  were  prepared  over a 
wide range of pH at ionic strength 0.15 (14). 
N-Aeetyl-z-tyrosine ethyl ester, a substrate to test esterase activity, was synthesized in the 
Department of Chemistry, Western Reserve University. It was dissolved to a  1.6 M solution 
in 2-methoxyethanol (methyl cellosolve). 
p-Toluenesulfonyl-z-arginine  methyl ester  (H.  M.  Chemical Co.),  a  substrate hydrolyzed 
by both esterase and plasmin, was dissolved in a concentration of 0.16 M in phosphate buffer. 
Pneumococcal  specific-soluble  substance,  Type  III  (S-III),  1 was dissolved in 0.15 ~  NaCI 
to a stock concentration of 1 rag. per ml. 
Antipneumococcal  rabbit serum,  Type IH  (Anti-S-III),l a  refined and concentrated anti- 
serum containing 5  rag.  antibody nitrogen per ml.  (10), was diluted as required in 0.15  M 
NaCI. 
Complement-fixed  (CF)  serum  was  prepared  by  adding  200  /~g. of  anti-S-III  antibody 
nitrogen and 8 ;tg. of S-III per ml. of serum in a  final dilution of serum of 1.5-fold.  The mix- 
ture was incubated at 37°C. for 1 hour,  centrifuged at 0°C. at 4000 mP.M. for 1 hour, and 
the clear supernatant solution retained at 0*C. for use on the same day. 
Streptokinaee  ("varidase" or  "high purity"),  1 the filterable principle of cultures of  beta 
hemolytic  streptococci  which  activates  plasminogen,  was  dissolved  in  distilled  water  or 
sodium chloride solution to a  suitable concentration. 
Streptokinase-treated  (SK)  serum was prepared by adding one-half volume of a  dilution 
of  streptokinase containing 2000 units per ml.  to one volume of serum and  incubating at 
37°C.  for 1 hour. The resulting treated serum, diluted  1.5-fold  with respect to the original 
serum, was held at 0°C. for use on the same day. 
Amberlite IRC-50 (sodium  cycle), adjusted to pH 7.7-7.8, was prepared from the hydrogen 
cycle (Fisher Scientific Company, Pittsburgh) as previously described (15). 
Disodium  ethylenediaminetetraacetic  acid  (EDTA)  (Bersworth Chemical Company,  Fram- 
ingham, Massachusetts) was dissolved in distilled water and adjusted to pH 7.4 with sodium 
hydroxide at a  final concentration of 0.15 M. 
Crystalline soy bean inhibitor  (Nutritional Biochemicals Company) was dissolved variously 
in phosphate buffer or in 0.15 M NaC1 to a concentration of 10 mg. per ml. 
Methods 
A  unit of complement  is defined as the smallest amount of fresh serum which will cause 
complete hemolysis of 1 ml. of a  standardized suspension of sensitized sheep cells in a  final 
a Provided through the courtesy  of Lederle Laboratories Division,  American Cyanamid 
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volume of 1.5 ml. after 30 minutes at 37°C.  (1,  10). The volume unit of R1, R2, R3, and R4 
was based on the complement unit of the serum from which these reagents were prepared. 
Titrations of individual components of complement were carried out according to general 
methods described elsewhere  (1,  10,  16).  The sample to be titrated was diluted serially in 
barbital-Ca++-Mg  +'+ buffer in an ice bath. In the case of C'I an initial dilution in an equal 
volume of R1 was made, prior to further dilution in buffer, in order to prevent activation of 
partially purified  C'I  which could  otherwise occur  under  the  conditions of  titration  (4). 
To a series of 12 X  75 ram. tubes in an ice bath, 0.2 ml. of the sample dilutions, a constant 
amount of reagent (5 units of R1, 2 units of R2, 3 units of R3, or 3 units of R4, depending 
upon the component to be titrated) and 1 ml. of sensitized sheep cells were added. The tubes 
were mixed,  incubated at 37°C.  for 30 minutes,  centrifuged at  2000 R.P.,J.  for 5  minutes, 
and compared visually with a  50 per cent hemolytic standard. The titer was expressed as. 
the reciprocal of the sample dilution which gave 50 per cent hemolysis. This value multiplied 
by 5 gave the number of units of component per milliliter of sample. The endpoint was read 
to the nearest half-tube; for example, ff a  dilution of 1:64 gave 70 per cent hemolysis and 
1:128 gave 30 per cent hemolysis, the cndpoint was taken at  1:96 and the titer expressed 
as 480 units per ml. Criteria for the suitability of complement reagents and limitations o| 
the double dilution titration procedure are discussed elsewhere (1,  10,  16,  17). 
Esterase activity was measured by micro-formol titration of the acid liberated from N-ace- 
tyl-L-tyrosine ethyl ester after incubation with enzyme at 37°C. for 15 minutes at pit 7.4, 
ionic strength 0.30,  and a  substrate concentration of 0.08  ~  (3-5,  7).  The relatively high 
ionic strength was chosen to  inhibit further activation of  C'I  during the assay procedure 
(4), without interfering seriously with esterase activity (5). Typically, 1.50 ml. of phosphate 
buffer, 0.5 ml. of M NaCI, and 0.375 ml. of an appropriate enzyme dilution were mixed and 
incubated at 37°C. At zero time, 0.125 ml. of 1.6 *J N-acetyl-L-tyrosine ethyl ester in methyl 
cellosolve at  37°C.  was added  to  the enzyme-buffer mixture.  Samples of  1 ml.  of  the en- 
zyme-buffer-substrate mixture were removed at the start and after 15 minutes of incubation 
at 37°C., mixed with 1 ml. of a 37 per cent solution of neutralized formaldehyde, and micro- 
titrated with 0.05 N sodium hydroxide using 2 drops of 1 per cent alcoholic phenolphthalein 
as the indicator. Suitable control experiments were performed, omitting enzyme or substrate 
from the mixture.  Esterase activity was expressed as the difference, in milliliters of 0.05  N 
NaOH,  between the titrations for the 15 minute and zero time aliquots. All titrations were 
performed  with a  1  ml.  micro-syringe  (Micrometric Instrument  Corporation,  Cleveland). 
Nitrogen was determined by a modification of the micro-Kjeldahl procedure of Pregl. 
Electropkoreti¢ analyses were performed in a  Perkin-Elmer electrophoresis apparatu  s in 2 
ml. cells,  using 0.5 per cent protein solution and buffer consisting of 0.28 M NaC1 and 0.02 ~, 
sodium acetate-acetic acid buffer at pH 5.5. 
RESULTS 
1.  The Influence o/Temperature on the Rate o/Activation  of Partially Purified 
C'l.-- 
The rates of disappearance of hemolytically active, partially purified C'I and of appear- 
ance of esterase activity were measured as a function of temperature at pH 7.1, ionic strength 
0.15,  and an initial concentration of C'I in the final reaction mixture of 2500 units per mh 
At the desired temperature, one part of partially purified C'1 at pH 5.5, ionic strength 0.30, 
was mixed with 2 parts of pH 7.4 phosphate buffer, ionic strength 0.075. Aliquots were with- 
drawn at frequent time intervals and assayed for C'I titer, esterase activity, or both. Typical I.  H.  LEPOW~ O.  D.  RATNOYY~ AND  L.  R.  LEVY  455 
rate curves for C'I disappearance are shown in Fig.  1. The correlation between the time of 
C'1 disappearance and of esterase appearance is demonstrated in Table I. 
Mixed temperature experiments revealed that the rate of activation at a  given tempera- 
ture could be reduced by lowering the temperature during the course of the reaction and 
could be restored to its initial value by re-establishing the original temperature. 
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Fxo.  1.  The rate of  disappearance of hemolytieally active, partially purified  C'I  as  a 
function of temperature, at pH 7.1,  ionic strength 0.15, initia  concentration of C'1 of 2500 
units per ml. 
TABLE  I 
A  Comparison of the  Time Required for  Complete Disappearance of Hemolytically A¢ff~e, 
Partially Purified C'I and for Comflete Adiva~ion of Esterase Activity, 
as a Function of Temperature 
Temperature 
°C. 
37 
25 
20 
15 
Time required for 
Disappearance of C'1 
m/n. 
3.5-4 
9  -11 
20  -24 
50  -6O 
Appearance of esterase 
mln. 
3-4 
8-10 
15-20 
4O-6O 
pH 7.1,  ionic strength 0.15, initial concentration of C'I of 2500 units per ml. 456  ACTIVATION"  OF  A  PROESTERASE 
Within the limits of experimental error, the curves in Fig.  1 conform to the equation for 
second order autocatalysis. The integrated form of this equation (18), 
1  a(b Jr x) 
k  t(a +  b) In b~a --~ x)' 
may be used to calculate k, the spedfic reaction rate. Such calculations may be made on the 
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Fxo.  2.  A  comparison of  the theoretical curve calculated from the equation for second 
order sutocatalysis with experimental values for the rate of disappearance of hemolytically 
active, partially purified C'I at 20°C.  and at pH  7.1,  ionic strength 0.15,  initial concentra- 
tion of C'1 of 2500 units per ml. 
following empiric basis: 
a  -- units per milliliter of C'1 present at time tt. 
b =  (units per milliliter of Cq  present at time to)  -  (units per milliliter of C'1 present 
at time h). 
x  --  (units per milliliter of C'I present at time h)  -  (units per milliliter of C'! present 
at time t~). 
t  == t2 -  h, in minutes. 
For example,  employing the data represented in  Fig.  l,  the average value for k  has been 
found to be 0.000133  rain.  -1 at 20°C.  Comparison of the experimental and theoretical curves 
at this temperature is shown in Fig. 2. It will be noted that, except at the beginning of the I.  H.  LEPOW~  O.  D.  RATNOIrF~  AND  L.  R.  LEVY  457 
reaction, the experimental values fit the theoretical curve calculated from the equation for 
second order autocatalysis. The apparent discrepancy during the first 6 minutes is attributa. 
ble to the inability to measure small changes in C'1 at high initial concentrations of C'1 by 
the assay procedure employed in this study. The kinetics of activation of C'1  to esterase, 
conforming to second order autocatalysis, are identical in type with those for the conversion 
of pepsinogen to pepsin (19) and trypsinogen to trypsin (20). 
The energy of activation for the conversion of C'1 to esterase was calculated, using the 
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Fxo. 3. Arrhenius plot of the data in Fig.  1. 
Arrhenius equation (21) : 
V  ~ffi  z$  -I~IRT 
in which F  ffi  the velocity of the reaction, z  ffi  a  constant, e  ffi  the base of natural loga- 
rithms,  T  ffi  absolute temperature, R  ffi  the gas constant, and #  =  the critical thermal 
increment or energy of activation. The velocity of the activation reaction at each tempera- 
1 
ture studied was defined as -  X  I(P, in which t  ffi  the time in minutes for complete disap- 
l 
pearance of hemolytic C'1 activity. A plot of the logarithm of velocity versgs the reciprocal 
of the absolute temperature gave a  straight line (Fig. 3)  at temperatures between  10  ° and 
25°C. From the slope of this line, a value of about 31,000 calories per tool was calculated  for 
the energy of activation. The slope of the line and the value for/~ were unchanged by defin- 
ing the velocity of the reaction in terms of S0 per cent disappearance of hemolytic C'1 ac- 458  ACTIVATION  O1  ~ A  PROESTERASE 
tivity. In biological systems, the value tt has also been called "the temperature characteris- 
tiC" (22) and may not be identical with the energy of activation. The value for bt of 31,000 
calories per mol for the activation of C'1  to esterase may be compared with the value of 
12,000 calories per tool for the hydrolysis of N-acetyl-L-tyrosine ethyl ester by the activated 
esterase (5). 
2.  The Influence of pH on the Rate of Activation  of Partially Purified C'1.  I 
The rate of disappearance of hemolytically active, partially purified C'I and of appear- 
ance of esterase activity was measured as a  function of pH at ionic strength 0.15  and  an 
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Fro. 4. The rate of disappearance  of hemolytically active, partially purified C'I and of 
activation of esterase as a function of pH, at 20°C. for 30 minutes, ionic strength 0.15, initial 
concentration of C'1 of 1000 units per ml. 
initial concentration of C'1 of 1000 units per ml., during 30 minutes' incubation at 20°C. 
One part of partially purified C'I at pH 5.5,  ionic strength 0.30 was mixed with 4 parts of 
Michaelis' acetate-barbital-saline buffer at ionic strength  0.15  and  at the desired pH,  and 
with  1 part  of distilled water.  All reagents were pre-incubated  at  20°C. prior  to  mixing. 
Aliquots were withdrawn at the start and after 30 minutes' incubation at 20°C. and assayed 
for C'1 titer, esterase activity, or both. The pH of the final reaction mixture was measured 
at room temperature at the end of the incubation period. 
The results of these experiments are plotted in Fig. 4. It will be noted that the 
pH  optimum  both  for  disappearance  of  C'1  and  for  appearance  of  esterase 
activity lies at  pH  7.3-7.7.  Inhibition  is progressively more  marked  on  each I.  H.  LEPOW~ O.  D.  RATNO]~F~ AND  L.  R.  LEVY  459 
side of these pH values and is complete below pH 6 and above pH 9 under the 
conditions of the experiment. The pH optimum of 7.3-7.7 for the activation of 
C'I  to estemse may be compared with  the pH  optimum  of 7.5-8.2  for the 
hydrolysis of N-acetyl-L-tyrosine ethyl  ester  by  the  activated  esterase  (5). 
3.  The Influence of Ionic Strength on tke Rate of Activation  of Partially Puri- 
fied C'1.-- 
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FIc. 5. The rate of disappearance of hemo]ytically  active, partially purified C't and of 
activation of esterase as a function of ionic strength, at 20°C. for 30 minutes, pH 7.1, initial 
concentration of C'I of 1500 units per ml. 
The rate of disappearance of hemolytic.ally active, partially purified C'I and of appear- 
ance of esterase activity was measured as a function of ionic strength at pH 7.1 and an ini- 
tial concentration of C'I of 1500 units per ml., during 30 minutes' incubation at 20°C. Dilu- 
ents of known ionic strength were prepared by mixing 1 part of pH 7.4 phospl~te buffer of 
ionic strength 0.15 with 4 parts of distilled water or of a  sodium chloride solution of appro- 
priate ionic strength. One part of partially purified C'1 at pH 5.5, ionic strength 0.30 at 20°C. 
was mixed with 5 parts of diluent at 20°C. Aliquots were withdrawn at the start and after 
30 minutes' incubation at 20°C. and assayed for C'1 titer, esterase activity, or both. 
The results of these experiments, plotted in Fig. 5, demonstrate that activa- 
tion depends upon the presence of a  critical ionic strength. Inhibition both of 
C'I  disappearance and of esterase appearance occurred above ionic strength 
0.15. In separate experiments, this was found to hold even if the activation re- 460  ACTIVATION  OF A  PROESTERASE 
action were started at ionic strength 0.15  and the ionic strength subsequently 
elevated. Advantage has been taken of this observation in this investigation by 
performing assays for esterase activity at ionic strength 0.30,  thus inhibiting 
further  activation  of  C'1  during  the  procedure.  Under  the  conditions of  the 
experiments inhibition was complete at ionic strength 0.225. The marked effect 
of ionic strength on the activation of C'I to esterase may be compared with the 
small and gradual inhibition of esterase activity at ionic strengths of 0.25 and 
above (5). 
4.  The Influence  of Cation Exchange, EDTA, and Ca  ++ and Mg  ++ on the Rate 
of Activation  of Partially Purified C'I.-- 
It was known from previous investigations (1, 2, 15) that the inactivation of 
complement both by antigen-antibody aggregates and by plasmin is potentiated 
by Ca  ++ and that this inactivation is very probably a  result of activation of a 
proenzyme  (C'I)  (1-4).  It was  also known  that  divalent cations are not  in- 
volved in the activity of activated C'I against synthetic amino acid esters (5). 
Accordingly, it was of interest to study the effect of Ca++ on the activation of 
C'I to esterase. 
In the first group of experiments,  reagents were cation-exchanged  with amberlite IRC-50 
in the sodium cycle (15). All glassware was scrupulously  cleaned and copiously rinsed with 
ion-exchanged water with a resistance of at least 106 ohms (bantam demineralizer, Bamstead 
Still and  Sterilizer Company,  Boston,  Massachusetts),  At  20°C., one part  of cation-ex- 
changed,  partially purified  C'1 at pH 5.5, ionic  strength 0.30 was mixed with 4 parts of 
cation-exchanged  Michaelis' acetate-barbital-saline  buffer at pH 7.9, ionic strength 0.15 and 
with 1 part of ion-exchanged water. The final pH of the reaction mixture was 7.5, The rate 
of disappearance of hemolytic C'1 activity from this mixture at 20°C. was compared with 
the rate of C'1 disappearance from similar mixtures containing 2.5 X  10  -8 M Ca  ++ or 8  X 
10  -4 K Mg  ++ and with the rate of C'1 disappearance from non-exchanged mixtures with and 
without added Ca  ++ or Mg++ (10  -8 to 10  -3 ~t). No significant differences in rate could be de- 
tected among any of these mixtures. 
Thus,  although  cation-exchanging  with  amberlite  IRC-50  in  the  sodium 
cycle resulted in inhibition of inactivation of complement by plasmin and to a 
lesser extent  by  antigen-antibody aggregates  (1,  2,  15),  this  procedure  was 
without significant effect on the activation of partially purified C'I to esterase. 
In the second group of experiments,  the same experimental conditions were employed, 
except that reagents were  not cation-exchanged  and,  except for controls,  one  part of an 
appropriate concentration of EDTA was substituted for water. EDTA in concentrations as 
low as 5 X  10  --s ~  in the final mixture completely inhibited disappearance of C'I and ap- 
pearance of esterase during 30 minutes incubation at 20°C., at pH 7.5, ionic strength 0.15. 
The inhibition curve was extremely sharp; 1 X  10  -8 Is EDTA was without effect. The  in- I. H. LEPOW, O. D. RATNOFF,  AND  L. R. LEVY  461 
hibition of C'I disappearance  by EDTA could be overcome by equlmohr concentrations of 
Ca  ++ or by 10-fold  greater concentrations  of Mg  ++, as shown  in Table H. 
TABLE II 
BJext of EDTA and of Ca  ++ and Mg  ++ on tke Rate of Disappearance or Hemolytically Active, 
Partially Purified C'I and of Appearance of Ecterase Activity 
EDTA  Ca  ++  MS++  Disapl~a~ance of  AppearanCeesterase  of 
M 
0 
10--4 
10-~ 
10-4 
10-4 
10-4 
M 
0 
0 
0 
0 
10-4 
10-s 
M 
0 
0 
10-4 
10-s 
0 
0 
per ce~g 
90 
0 
0 
80 
9O 
95 
I00 
0 
pH 7.5, ionic strength 0.15, initial concentration  of Ctl of 1300 units per ml., 20°C. for 
30 minutes. 
Inhibition by EDTA was completely reversible by dialysis. Partially purified 
C'I at pH 5.5, ionic strength 0.30 was treated with EDTA to a final concentra- 
tion of 10  -3 ~ and dialyzed at 0°C. for 24 hours against 1000 volumes of a buffer 
mixture consisting of 0.29 M NaC1 and 0.01 M acetate buffer of pH 5.5. A con- 
trol sample without EDTA was dialyzed separately under the same conditions. 
The dialyzed samples were then brought to pH 7.5, ionic strength 0.15, and in- 
cubated at 20°C. for 30 minutes, as described above. No significant difference 
in the rate of C'I disappearance could be detected between the two samples, 
indicating that EDTA inhibition had been overcome by dialysis, while readdi- 
tion of EDTA to the dialyzed samples restored complete inhibition. 
These experiments showed, therefore, that the activation of C'I to esterase 
was inhibited by small concentrations of EDTA and that this inhibition could 
be reversed by equimoiar concentrations of Ca  ++, by larger concentrations of 
Mg  ++, and by removing the EDTA by dialysis. It appeared possible that in- 
hibition by EDTA was due to chelation of tightly bound Ca  ++ on the  Ctl 
molecule, not dissociable by amberlite IRC-$0. However, a  second possibility 
exists that EDTA was directly bound to C'I without a metal ion intermediary. 
Indeed,  semi-quantitative  spectrographic  analysis  of  partially  purified  Ctl 
(National Spectrographic Laboratories,  Inc.,  Cleveland) failed to reveal sig- 
nificant amounts of any polyvalent metal ion. 
5.  The Influence of Initial Concentration  of C'1 and of Esterase on the Rate of 
Activation of Partially Purified C'I.-- 
The observation that the activation of C'I to esterase followed the kinetics for 
second  order  autocatalysis suggested  that  the  rate  of  activation would  be 462  ACTIVATION  O1~ A  PROESTERASE 
functions of initial concentrations of Ctl and of esterase. Experiments designed 
to test the validity of this prediction were therefore carried out. 
The effect of initial  C'1 concentration  was studied at 20°C., pH 7.1, ionic strength  0.15. 
At 20°C., one part of partially  purified C'1 at pH 5.5, ionic strength  0.30 was mixed with 2 
parts of pH 7.4 phosphate  buffer, ionic strength 0.075, and with appropriate  volumes of 0.15 
NaCI to give initial C'1 titers of 1920, 960, and 240 units per ml. Aliquots were withdrawn 
at frequent intervals and titrated for Cq. 
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Fio. 6. The rate of disappearance of hemolytically active, partially purified C'1 as a func- 
tion of initial C'I concentration, at 20°C., pH 7.1, ionic strength 0.15. 
The results given in Fig. 6 demonstrate that the rate of reaction does indeed 
increase  with  increasing  initial  C'I  concentration.  However,  the  rate  is  not 
directly  proportional  to  C'I  concentration,  as  would  be  predicted  from  the 
kinetic equation for second order autocatalysis. Thus, a  4-fold increase in C'1 
concentration, from 240 to 960 units per ml., resulted in only 2.3-fold increase 
in rate; a  2-fold increase in Cq concentration, from 960 to 1920 units  per rot., 
resulted in only 1.7-fold increase in rate. This smaller than predicted  effect of 
initial proenzyme concentration on reaction rate has also been observed in the 
autocatalytic activation of pepsinogen (19). 
The  effect  of  initial  esterase  concentration  was  also  studied  at  20°C., pH  7.1, 
ionic strength 0A5, and an initial concentration  of Cq of 2000 units per ml. Activated  Cq 
was first prepared by adjusting partially  purified C'I to pH 7.4, ionic strength 0.15 by dilut- I.  H.  LEPOW, O.  D.  RATNOFF, AND  L.  R.  LEVY  463 
ing with an equal volume of water and adding 0.5 N NaOH. The resulting solution,  diluted 
about 2-fold with respect to the original C'I, was incubated at 37°C. for 15 minutes to assure 
activation and then stored in the cold. Reaction mixtures were then prepared at 20°C. by 
mixing one part of partially purified  C'1 at pH 5.5, ionic strength 0.30; 2 parts of pH 7.4 
phosphate buffer, ionic strength 0.075; and 2 parts of an appropriate dilution of preformed 
esterase in 0.15 ~ NaC1. Aliquots were withdrawn at frequent intervals and titrated for C'1. 
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Fro. 7. The rate of disappearance of hemolytically  active, partially purified C'I as a func- 
tion of initial esterase concentration, at 20°C., pH 7.1, ionic strength 0.15, initial concentra- 
tion of C'1 of 2000 units per ml. 
The data are presented in Fig. 7, in which the initial concentration of esterase 
is expressed as a  ratio of initial esterase to initial C'1  concentrations,  on  an 
equivalent volume basis. Thus, if one put  of partially purified C'1 were mixed 
with a  buffer diluent containing 0.5 part of preformed esterase (diluted 24old 
with respect to the original C'1), the ratio of initial esterase to initial C'1 con- 
was taken as 0"51/2-- =  0.25. It will be noted in Fig. 7 that the rate of  centrations 
disappearance of C'I increased with increasing initial concentration of esterase 
in accordance with prediction for an autocatalytic reaction. However, as in the 
case of the experiments on initial C'1 concentration, the rate was not directly 
proportional to initial esterase concentration, a phenomenon also noted for the 
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6.  Inhibition  of Activation of Partially Purified C'I  by Human  Serum  and 
Serum Reagents.- 
It was observed earlier (4) that fresh human serum or R1, the serum reagent 
deficient in the first component of complement, inhibited the activation of C'I 
to esterase. This observation has been of great technical aid as a means of pre- 
venting activation during the titration of partially purified C'I and of stopping 
the  activation reaction in the  kinetic studies described  in  this  report.  Pre- 
liminary investigation of  the nature of the serum inhibitor will be described 
here with particular reference to its possible relation to components of comple- 
ment. 
At 20°C., one part of C'1 at pH 5.5, ionic strength 0.30 was mixed with one part of dis- 
tilled water and four parts of a solution consisting of various ratios of Michaelis' acetate- 
barbital-saline buffer of pH 7.7, ionic strength  0.15 and of the serum reagent to be tested 
for inhibitory activity. These reaction mixtures, at pH 7.4-7.5, ionic strength 0.15, and an 
initial concentration of C'1 of 2500 units per ml., were incubated at 20°C. for 40 minutes. 
C'1 titers  were obtained at the start and end of incubation.  The results  (Table III) were 
expressed in relative inhibition  units, arbitrarily defined as twice the reciprocal of the volume 
of undiluted serum reagent required to effect 50 per cent inhibition of C'I dissappearaace 
under the conditions described. 
TABLE III 
Some Ckaracteristics of the Factor(s) in Human Serum Inhibit'rig Spontaneous Activcaion of 
Partially Purified C'I 
Relative 
Serum reagent  C'1  C'2  C'3  C'4  iuhibition* 
Fresh serum 
48°--30 rain. 
520__30  ,, 
560__30  ,, 
R2~ 
R3~ 
R45 
CF$ 
SK$ 
IO0 
IO0 
5 
0 
0 
50 
75 
75 
5 
5 
~r CenJ 
IO0 
70 
0 
0 
70 
0 
70 
70 
0 
0 
~r c~t 
IO0 
70 
4O 
25 
15 
50 
0 
8O 
5O 
6O 
tO0 
75 
75 
5O 
40 
25 
45 
0 
0 
0 
100 
100 
40 
10 
65 
5 
I00 
65 
75 
5 
pH 7.4.-7.5, ionic strength 0.15, initial concentration of C'1 of 2500 units per ml., 20°C. 
for 40 minutes. 
* For definition, see text. 
R1, R2,  R3, and R4 refer to serum reagents deficient in the first, second, third, and 
fourth components of complement, respectively. CF and SK refer to serum treated with 
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The serum inhibitor (or inhibitors)  were found to withstand incubation at 
48°C. for 30 minutes. However, about 50 per cent of the inhibitory activity of 
serum was destroyed at 52°C. for 30 minutes and about 90 per cent at 56°C. 
for  30  minutes.  Thus,  the  inhibitor  was  relatively heat-labile.  Among  the 
specifically inactivated complement reagents,  R1,  R2,  R3,  and R4,  only R2 
(the serum  fraction deficient in  the  second component of complement)  was 
markedly deficient in  the inhibitor. However, C'2  activity is completely de- 
stroyed at 50--52°C. for 30 minutes and is therefore more heat-labile than the 
serum  inhibitor.  Furthermore,  C'2  is  completely inactivated  under suitable 
conditions by treatment of serum with antigen-antibody aggregates (comple- 
ment-fixed serum) or with plasmin (streptokinase-treated serum) (23). Never- 
theless, complement-fixed serum retained most of its inhibitory activity, while 
streptokinase-treated  serum  was  almost  entirely  lacking  in  inhibitor.  The 
susceptibility of  the  inhibitor  to  inactivation by streptokinase  was  not  ex- 
plained. Thus, the factor (or factors) in human serum responsible for inhibition 
of activation of C'I resembled C'2 in some of its properties but could be dis- 
tinguished from it. 
These findings on the properties of the serum inhibitor of the activation of 
C'I are in complete accord with those found for the serum inhibitor of esterase 
activity against  synthetic amino  acid  esters  (5).  This  agreement  would  be 
expected for an autocatalytic reaction, in which inhibition of the active enzyme 
would effect inhibition of activation of the proenzyme. 
7.  Activation  of Partially Purified C'1 to Esterase by Streptokinase-Activated 
Plasmin.-- 
The inhibition of complement activity by plasmin has been attributed  to 
reactions involving at least two steps (1). It was suggested that plasmin con- 
verted C'I  to an enzyme which in turn inactivated C'2 and C'4.  In the ex- 
periments to be described,  evidence is presented confirming the presence of 
plasminogen in partially purified preparations of Cq, and demonstrating that 
pla.qmin  activates the esterase. These experiments take advantage of several 
earlier observations: (a)  C'I  and the esterase are inactivated at 53°C.  (5), a 
temperature at  which  plasminogen  and  plasmin  are  stable;  (b)  the  esterase 
digests both p-toluenesulfonyl-L-arginine methyl ester and N-acetyl-L-tyrosine 
ethyl ester (3, 4), whereas plasmin digests only the former substrate (7); (c) soy 
bean trypsin inhibitor inhibits the action of plasmin, but not of the esterase (5). 
A preparation of C'I was divided into two portions, one of which was incubated at 53°C. 
or 30 minutes. Aliquots of 0.25 ml. of each were then incubated at 37°C. for  15 minutes 
with 0.75 ml. of a solution of streptokinase (10,000 units per ml.) in 0,3 ~ sodium chloride. 
Each preparation was then tested for its ability to hydrolyze N-acetyb~.-tyrosine  ethyl ester 
or p-toluene, alfonyj-g-arginine  methyl ester, maintaining ionic strength at 0.3 by the addi- 
tion of hypertonic sodium chloride solution. In control experiments, either 0.3 M or 0.15 ~r 
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The addition of streptokinase to unheated C'I resulted in hydrolysis of both 
N-acetyl-r-tyrosine ethyl  ester and p-toluenesulfonyl-L-arginine methyl ester. 
On  the  other  hand,  the  addition  of streptokinase  to  heated  C'I  resulted  in 
hydrolysis of the p-toluenesulfonyl-L-arginine methyl  ester  alone  (Table IV). 
The same result was obtained by activating C'I by lowering the ionic strength 
to  0.15,  although  the  digestion  of  p-toluenesulfonyl-L-arginine methyl  ester 
was much  less  impressive in  the  absence  of streptokinase. 
TABLE IV 
The Effect of Streptokinase  on Heated and Unheated C'I 
Activating agent 
I.  Unheated C'I 
Streptokinase 
Sodium chloride solution 
Sodium chloride solution 
[I. C'I heated at 53°C. 30 rain. 
Streptokinase 
Sodium chloride solution 
Sodium chloride solution 
Ionic strength 
during activation 
0.3 
0.3 
0.15 
0.3 
0.3 
0.15 
Esterase activiW 
microequivalents of acid 
liberated in 15 rain. 
es. N-ALTEe*  es. TAMeSt 
2.5 
0.3 
6.2 
0.2 
0 
0.1 
7.7 
0.8 
1.8 
3.2 
0.9 
1.1 
* Versus N-acetyl-L-tyrosine ethyl ester at ionic strength 0.30. 
~t Versus p-toluenesulfonyl-L-arginine  methyl ester at ionic strength 0.30. 
These experiments confirm the view that partially purified preparations  of 
C'1 contain plasminogen and that the addition of streptokinase to C'I resulted 
in  the  appearance  of  esterase  activity.  The  following  experiments  demon- 
strated that the appearance of esterase activity could be prevented by inhibit- 
ing the action of plasmin. 
A volume of 0.3 ml. of streptokinase (10,000 units per ml.) in 0.3 st sodium chloride solu- 
tion was incubated for 30 minutes at 20°C. with 0.3 ml. of C'I and 0.3 ml. of phosphate 
buffer or of a solution containing 3 nag. of soy bean inhibitor per ml. of phosphate buffer. 
An aliquot was then removed and assayed for its ability to hydrolyze N-acetyl-r.-tyrosine 
ethyl ester at ionic strength 0.3 and in the presence of soy bean inhibitor in a final concen- 
tration  of 1 rag. per ml. Control experiments were performed in which either 0.3 st or 0.15 st 
sodium chloride was substituted for the solution of streptokinase. 
In this experiment, the addition of soy bean inhibitor prevented the activa- 
tion of esterase by streptokinase, but was without effect on the activation of 
esterase by the adjustment of ionic strength to 0.15  (Table V). This observa- 
tion supports the hypothesis that the activation of the esterase by streptokinase 
proceeds in two stages: (a) the activation of plasmin by streptokinase, and (b) 
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TABLE V 
The Effect of Soy Bean Inkibitor on Aaivation Of C'1 by Streptokinase and by Adjustment of 
Ionic Stren fh 
Ionic strength  Esterase activity* 
microequivalents of acid  Activating agent  during activation  liberated  in 60 rain. 
Streptokinase +  phosphate buffer 
Streptokinase +  soy bean inhibitor 
Sodium chloride +  phosphate buffer 
Sodium chloride +  soy bean inhibitor 
Sodium chloride +  phosphate buffer 
Sodium chloride +  soy bean inhibitor 
0.25 
0.25 
0.25 
0.25 
0.15 
0.15 
5.3 
2.5 
2.0 
2.4 
16.9 
17.0 
* Versus N-acetyl-T.-tyrosine  ethyl ester at ionic strength 0.30 with a concentration of 1 
mg. per ml. of soy bean inhibitor in the assay mixture. 
of C'I by adjustment of ionic strength did not seem to require the presence of 
plasmin since it was not blocked by soy bean inhibitor. 
8.  Attempted Demonstration of a Gross Alteration of C'l Following Activation 
to Esterase.-- 
It was apparent that the activation of C'I to esterase was similar in many 
respects  to  the  activation  of pepsinogen  to  pepsin  (19)  and  trypsinogen  to 
trypsin  (20).  Accordingly,  it  was  of  interest  to  attempt  to  demonstrate  a 
chemical  alteration  of  Ctl  following  activation  to  esterase.  In  the  case  of 
pepsinogen, autocatalytic activation is accompanied by release of a  pepsin in- 
hibitor, a polypeptide fragment with a molecular weight of 5,000 and soluble in 
trichloracetic  acid  (24),  while  activation of trypsinogen  to  trypsin  does not 
result in a gross chemical change (25). 
Activation of Cq to esterase was not accompanied by release of trichloracetic 
acid-soluble nitrogen. Neither partially purified C'I nor esterase contained any 
nitrogen  soluble in 2.5  per cent final concentration  of trichloracetic acid.  At 
lower concentrations of trichloracetic acid, no significant differences were found 
between the soluble nitrogen  in the partially purified  Cq  and in the esterase 
derived from it. 
Similarly, no significant differences were observed between the electrophoretic 
patterns of partially purified C'I and of esterase. A three component system of 
indistinguishable  distribution  and  mobility  was  obtained for  both  samples. 
Determinations  were  made  in  a  Perkin-Elmer  electrophoresis  apparatus  2 at 
pH 5.5, ionic strength 0.30 at a protein concentration of 0.5 per cent. 
2 We are  indebted to  Dr. Howard Bensusan of the Departments  of Biochemistry and 
Medicine, Western Reserve University,  School of Medicine, for  the  use  of  his  electro- 
phoresis apparatus  and for his interest and advice in this phase of the investigation. 468  ACTIVATION  OF  A  PROESTERASE 
The activation of partially purified C'I to esterase appeared to be irreversible. 
Adjustment of activated esterase to pH 5.5, ionic strength 0.30, at 0°C. for time 
intervals up to  40 hours failed to result in the reappearance of C'1  activity. 
DISCUSSION 
It has been shown that under a wide range of conditions of pH, ionic strength, 
time,  temperature,  and  inhibitor  concentration,  a  positive correlation  exists 
between the rate of disappearance of hemolytically active,  partially purified 
first component of human complement, and the rate of activation of an esterase 
hydrolyzing N-acetyl-L-tyrosine ethyl ester and several other synthetic amino 
acid esters.  Such a correlation may be predicted from the hypothesis proposed 
earlier  (1-4)  that  the  first  component  of complement  exists  in  serum  as  a 
proenzyme  which  may  be  activated  by  an  antigen-antibody  reaction,  by 
plasmin,  or, in the partially purified  state, by adjustment of physico-chemical 
conditions.  The  experimental  realization  of  this  prediction  adds  important 
evidence in favor of the role of the first component as a proenzyme. 
Furthermore,  the kinetic characteristics of the disappearance  of first com- 
ponent activity and of the appearance of esterase activity were similar  to the 
kinetics of activation of certain intensively studied enzyme systems. Thus, the 
appearance of esterase activity, correlating  with disappearance  of first com- 
ponent activity, followed  the kinetics for second order autocatalysis.  In  ac- 
cordance with this observation, the rate of the activation reaction was increased 
by increasing  either the initial concentration of proenzyme (first component) or 
of esterase. The rate of activation was also influenced sharply by pH and ionic 
strength.  These  are  characteristics  also  of  the  activation  of  trypsinogen  to 
trypsin (20) and of pepsinogen to pepsin (19). Certain other characteristics of 
the activation of first component to esterase were particularly referable to the 
trypsinogen-trypsin system. As with trypsin, esterase activation was irrevers- 
ible, was not associated with the liberation of a detectable molecular fragment, 
and occurred either autocatalytically or catalytically. The catalytic activation 
of first component to esterase by plasmin appeared analogous in principle to the 
activation of trypsinogen to trypsin by enterokinase (26) and by mold kinase 
(27). 
The  proenzymatic  nature  of  the  first  component  of  complement  and  its 
activation  by antigen-antibody has also been suggested by Becker (28,  29), 
employing an entirely different approach. Extending an observation of Levine 
(30),  Becker has  shown  that  diisopropylfluorophosphate  (DFP),  a  known 
esterase inhibitor, inhibits the hemolytic activity of guinea pig complement by 
acting on the first component. He has shown further that sensitized  sheep cells 
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pig complement are capable of hydrolyzing p-toluenesulfonyl-L-arginine methyl 
ester, and that this esterase activity correlates quantitatively with the activity 
of first component on the ceils. We had shown previously that p-toluenesulfonyl- 
L-arginine methyl  ester  is  a  substrate  for  the  esterase  derived either  from 
partially purified first  component of human  complement or from eluates  of 
antigen-antibody aggregates treated with serum reagents containing first com- 
ponent (3, 4). Following the work of Levine and of Becker, we have been able to 
show an inhibiting effect of DFP on the activity of partially purified esterase, 
although only in relatively high concentrations (5). Thus, an increasing body of 
evidence is  accumulating  that  the first  component of complement is  a  pro- 
esterase. Ultimate proof will require much more highly purified preparations of 
first component than are now available. 
TABLE VI 
A  Comparison of the Activation  of First Component to Esterase with  the Hydrolysis  of 
N-Acetyl-L-Tyrosine  Ethyl Ester by the Activated Esterase 
Order of reaction 
Energy of activation  (calo- 
ries per mol) 
pH optimum 
Effect of ionic strength (#) 
Effect of EDTA 
Serum inhibitor 
Effect of streptokinase 
Esterase activity es. N-acetyI-L- 
Activation of esterase  tyrosine ethyl ester (5) 
Second order autocatalysis 
31,000 
7.3-7.7 
Sharply inhibited at #  > 
0.15 
Inhibited  by  5  x  10  -s  M 
EDTA 
Heat-labile;  unrelated  to 
components  of  comple- 
ment 
Activates esterase by activa- 
tion  of  plasminogeu  to 
plasmin 
Zero order 
12,000 
7.5-8.2 
Gradually inhibited at #  > 
0.25 
No effect 
Heat-labile;  unrelated  to 
components  of  comple- 
ment 
No effect 
A  comparison of the reaction leading to activation of esterase with the hy- 
drolysis of N-acetyl-L-tyrosine ethyl ester by the activated esterase is sum- 
marized in Table VI. It will be noted that the two reactions differ with respect to 
order of reaction, energy of activation, pH optimum, and the effect of ionic 
strength.  Such differences are to be expected for fundamentally different re- 
actions involving entirely different substrates. On the other hand, both reactions 
are inhibited by a  serum factor (or factors) with similar properties. This ob- 
servation is consistent with an autocatalytic activation reaction in which in- 
hibition of the active enzyme would inhibit activation of the proenzyme. The 
nature and mode of action of the serum inhibitor appears of great interest and is 470  ACTIVATION OF A  PROESTERASE 
under investigation. The existence of such an inhibitor would be demanded by 
teleologic argument to explain  the existence in normal blood of the proenzyme 
(first  component) rather than the active enzyme (esterase). 
The mechanism of inhibition of the activation reaction by ethylenediamine- 
tetraacetic acid (EDTA) remains unexplained at the present time. Unlike the 
serum inhibitor, EDTA does not affect esterase. Hence, if inhibition by EDTA 
is to be explained  by chelation of a necessary cation, it is necessary to invoke 
the assumption that  the cation is required only for the activation reaction. 
Furthermore, it is necessary to assume that the cation is tightly bound to pro- 
tein, since exhaustive dialysis of partially purified C'1 or cation-exchanging  with 
amberlite IRC-50 in the sodium cycle is without effect. It appears more prob- 
able that  EDTA inhibits  the activation  reaction by binding directly to the 
first  component.  The  available  observations  would  then  be  explained  by 
assuming  that  the  dissociation  constant  for  the  protein-EDTA  complex  is 
greater than for the calcium-EDTA complex  and suificiently large to permit 
reversibility by dialysis. 
Preparations  of  esterase  derived either  from  partially  purified  first  com- 
ponent  or  from  eluates  of  antigen-antibody  aggregates  treated  with  serum 
reagents containing first component have the ability to inactivate complement 
(3, 4).  The complement-inactivating  activity of these preparations correlates 
with their esterase activity and is directed primarily against the fourth com- 
ponent and,  to a  lesser extent, against  the second component.  "Fixation" of 
human  complement by aggregates of soluble antigen  and rabbit antibody is 
known to lead to disappearance of the hemolytic activities of the first,  second, 
and fourth components (1, 31).  Activation of first component by an antigen- 
antibody reaction, with resulting inactivation of second and fourth components, 
has therefore been proposed as a possible mechanism of complement-"fixation" 
(1--4). Accordingly,  it is of interest to compare the characteristics of the com- 
plement-"fixation" reaction with those presented in this paper for the activa- 
tion of first component to esterase. 
It  was demonstrated  previously (2)  that  complement-"fixation"  could be 
separated into at least two distinct reaction stages. The first,  designated the 
activation stage, involved the reaction of the antigen-antibody aggregate with 
first component and  led to the formation  of an  activated aggregate.  In the 
second stage, designated the transfer stage, the activated aggregate or a product 
derived from it inactivated the second and fourth components. A summary of 
the kinetic  characteristics  of these reaction  stages,  along  with  those of the 
activation  of first component  to esterase  as described in  this  paper,  is pre- 
sented in Table VII.  It is apparent  that  the characteristics  of the reaction 
leading to activation of first component to esterase parallel  closely those for the 
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TABLE VII 
A  Comparison of the Activation  and  Transfer Stages of Complement-"Fixation"  witk the 
Activation of First Component to Esterase 
Activation stage (2)  Transfer stage (2)  Activation of esterase 
Optimal  at low temperature 
(0oc.) 
Instantaneous at 0°C. 
Independent of pH between 
pH 6.5-9.5 
Slight  dependency  on ionic 
strength 
No effect of Ca  ++ 
Optimal  at higher  tempera- 
tures (_-> 37°C.) 
Occurs slowly at O°C.; more 
rapidly at higher tempera- 
tures 
pH optimum at or near pH 7 
Sharp  dependency  on  ionic 
strength, with optimum at 
0.15 
Potentiated by Ca  ++ 
Optimal  at  higher  tempera- 
tures (_~ 37°C.) 
Occurs  very slowly at  0°C.; 
more rapidly at higher tem- 
peratures 
pH optimum 7.3-7.7 
Sharp  dependency  on  ionic 
strength,  with  increasing 
inhibition  above  ionic 
strength 0.15 
Inhibited  by  EDTA  but 
mechanism does not neces- 
sarily involve Ca  ++ 
TABLE VIII 
Proposed Reaction Stages in Compl~ment-"Fixation" 
Proposed reaction  Previous nomenclature (2) 
1. Antigen-antibody  -{- first component  Activation stage 
2. Activation of first component to esterase 
3.  Inactivation of second and fourth components in pres-  Transfer stage 
ence of activated esterase 
The apparent paradox in this correlation is primarily a  result of the nomen- 
clature adopted earlier (2). On the basis of the present work, it is suggested that 
complement-"fixation" is at least a  three stage reaction.  As pictured in Table 
VIII, the first reaction,  corresponding to the previously designated activation 
stage, remains as the reaction between the antigen-antibody aggregate and first 
component. The previously designated  transfer  stage consists of at least  two 
reactions: the activation to esterase of first component which has reacted with 
antigen-antibody,  and  the  subsequent  inactivation  of the  second and fourth 
components  in the  presence  of esterase.  It may be pictured tentatively  that 
antigen-antibody  in  Reaction  1  (Table  VIII)  serves  to  separate  first  com- 
ponent from the serum inhibitor which normally prevents activation. It would 
be of importance  that little  of the inhibitor  is  taken up by antigen-antibody 
aggregates (Table III). In the effective absence of inhibitor,  Reaction 2 would 
then proceed by autocatalysis,  presumably on the surface of the antigen-anti- 
body aggregate.  The  esterase  so  activated  would  inactivate  the  second and 472  ACTIVATION  OF  A  PROESTERASE 
fourth components in Reaction 3. Reaction 1 has already been studied in some 
detail (2), while Reaction 2 is described in this report. The kinetic character- 
istics  of Reaction 3,  however,  are  incompletely determined  and  remain for 
continuing investigation. 
S~.RY 
It has been found that under a wide range of physico-chemical conditions a 
positive correlation exists between the rate of disappearance of hemolytically 
active, partially purified first component of human complement and the rate of 
activation  of  an  esterase  hydrolyzing N-acetyl-L-tyrosine ethyl  ester.  Both 
reactions follow the kinetic equation for second order autocatalysis, with  an 
apparent energy of activation of 31,000 calories per tool. They occur optimally 
at pH  7.3-7.7  and  are  inhibited  by ionic strengths  greater  than 0.15,  by 5 
×  10  -6 ~J ethyleuediaminetetraacetic acid, and by a heat-labile serum inhibitor 
which appears unrelated to any component of complement. The activation of 
first component to esterase resembles closely the activation of trypsinogen to 
trypsin. Partially purified first component, containing plasminogen, may also 
be activated to esterase by addition of streptokinase. 
The significance of these data with respect to the postulated existence of first 
component as a  proesterase and its possible role in complement-"fixation" is 
discussed. 
We wish to acknowledge  the interest of the late Dr. Louis Pillemer and his generous co- 
operation in making available equipment and materials which greatly facilitated this inves- 
tigation. This study could not have been completed without the technical assistance of Miss 
Ann M. Harris. 
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